oa Preface

This issue marks the beginning of the eighth year of Current Psychiatry Reviews and it is hard to believe that the time has passed so quickly! Thinking back to our beginning efforts in 2004-05, our overarching goal was to fill a major void in the psychiatric literature, namely to become the first journal devoted to rapid publication of comprehensive reviews of the most interesting and important topics in psychiatry, psychopathology, and mental health and we hope that you agree that we are accomplishing this mission. In this issue of Current Psychiatry Reviews, for example, there are four papers directly addressing therapeutics, including articles summarizing the state of the science pertaining to sleep and antidepressants, pharmacotherapy of pathological gambling, the safety profiles of second generation antipsychotics, and management of weight gain during treatment with SGAs or mood stabilizers, as well as a paper highlighting the potential therapeutic applications of intranasal oxytocin. With respect to classification, there are papers reviewing the comorbidity of alcoholism and bulimia nervosa and the neurobiological complexity of antisocial personality disorder. As Editor-in-Chief, it is gratifying to see such outstanding papers take form - sometimes beginning with a short abstract outlining the authors' ideas - and reach an increasingly larger audience. This process is depends on the efforts of dozens of peer reviewers, who donate hundreds of hours of time to help our authors sharpen, clarify, and strengthen their contributions. I also wish to thank the editorial staff of Bentham for their tireless efforts to ensure that papers are shepherded through the review process, deadlines get met, and infinitives go unsplit.